Validation of the BOADICEA model for epithelial tubo-ovarian cancer risk prediction in UK Biobank
BOADICEA, implemented in CanRisk ( www.canrisk.org ), provides valid 10-year EOC risks and can facilitate clinical decision-making in EOC risk management.
Authors
- Tim Carver (ORCID: https://orcid.org/0000-0003-1508-3091)
- Naomi Wilcox (ORCID: https://orcid.org/0000-0002-7709-7029)
- Jonathan P. Tyrer (ORCID: https://orcid.org/0000-0003-3724-4757)
- Lorenzo Ficorella (ORCID: https://orcid.org/0000-0002-0577-1571)
- Joe Dennis (ORCID: https://orcid.org/0000-0003-4591-1214)
- Antonis C. Antoniou (ORCID: https://orcid.org/0000-0001-9223-3116)
- Douglas F. Easton (ORCID: https://orcid.org/0000-0003-2444-3247)
- Marc Tischkowitz (ORCID: https://orcid.org/0000-0002-7880-0628)
- Xin Yang
- Yujia Wu (ORCID: https://orcid.org/0000-0002-0864-9790)
- Paul D.P. Pharoah (ORCID: https://orcid.org/0000-0001-8494-732X)
- Nora Pashayan
Institutions
- Cedars-Sinai Medical Center (US)
- University of Cambridge (GB)
- MRC Epidemiology Unit (GB)
Publication Details
- Journal
- British Journal of Cancer
- Published
- 2024-09-18
- DOI
- https://doi.org/10.1038/s41416-024-02851-z
- Citations
- 9
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.83
Funders
- Cancer Research UK
- National Institute for Health and Care Research
- Department of Health and Social Care
- NIHR Cambridge Biomedical Research Centre